Single-labeled oligonucleotide probes for homogeneous nucleic acid sequence analysis

• US 6,635,427 B2
• Filed: 08/10/2001
• Issued: 10/21/2003
• Est. Priority Date: 08/11/2000
• Status: Expired due to Term

• Current Assignee: Biofire Defense, LLC (Compagnie Merieux Alliance SAS), University of Utah Research Foundation (State of Utah)
• Original Assignee: Idaho Technology Inc (Compagnie Merieux Alliance SAS), University of Utah Research Foundation (State of Utah)
• Inventors: Chen, Jian, Caplin, Brian E., Kusukawa, Noriko, Crockett, Andrew O., Stevenson, Wade, Wittwer, Carl T.
• Primary Examiner(s): Horlick, Kenneth R.
• Application Number:
  US09/927,842
• Publication Number:
  US 20030022177A1
• Time in Patent Office: 802 Days
• Field of Search: 435/6, 435/91.2, 435/810, 536/24.3
• US Class Current: 435/6.11
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6818 involving interaction of two or more labels, e.g. resonant energy transfer
• CPC Class Codes: C12Q 1/6851 Quantitative amplification
• CPC Class Codes: C12Q 2525/185 incorporating bases where the precise position of the bases in the nucleic acid string is important
• CPC Class Codes: C12Q 2565/107 Alteration in the property of hybridised versus free label oligonucleotides

Abstract

Probes and methods are provided for detection and analysis of nucleic acid sequences. The probes are single-labeled oligonucleotide probes whose fluorescence emission changes in response to probe-target hybridization and dissociation. The methods are for analyzing one or multiple nucleic acid loci using the probes. This invention further relates to the use of fluorescence changes in single-labeled probes for melting curve analysis, genotyping, and pathogen detection, and to methods for quantification of specific sequences in real-time monitoring of nucleic acid amplification.

Claims

1. A fluorescence-based probe system for analyzing a target nucleic acid consisting essentially of

a single-labeled polynucleotide comprising a sequence generally complementary to a locus of the nucleic acid and a fluorescent label attached to a terminal nucleotide, wherein the terminal nucleotide is a base analog,

whereby upon hybridization of the single-labeled polynucleotide to the locus of the nucleic acid the fluorescent label is positioned near a residue of the target nucleic acid with a resultant increase in fluorescent intensity of the fluorescent label.

2. The probe system of claim 1 wherein the base analog is selected from the group consisting of 5-nitroindole, 4-nitroindole, 6-nitroindole, 3-nitropyrrole, 5-iodo-cytidine, inosine, and nubluarine deoxynucleosides.

3. The probe system of claim 1 wherein the target nucleic acid has a C residue in a position complementary to the terminal nucleotide.

4. A probe for analyzing a target nucleic acid comprising

a fluorescent detecting entity consisting essentially of a single-labeled oligonucleotide having a sequence generally complementary to a locus of the target nucleic acid and a fluorescent label linked to an internal residue of the oligonucleotide, the internal residue comprising a base analog, and

wherein the sequence of the probe is selected so that upon hybridization of the probe to the locus of the target nucleic acid the magnitude of fluorescent emission from the fluorescent label is altered by hybridization of the probe to the target nucleic acid.

5. The probe of claim 4 wherein hybridization of the probe to the target nucleic acid places a G residue in positions +1, 0, or −

1 relative to the position of the internal residue, and the fluorescent label is linked to the internal residue by a linker sufficiently flexible to allow quenching by the G residue.

6. A method for determining the presence of a target nucleic acid sequence in a biological sample comprising:

combining a single-labeled oligonucleotide probe with the sample, said probe having an oligonucleotide sequence generally complementary to a locus of the target nucleic acid sequence and a fluorescent label linked to a G residue of the oligonucleotide sequence, the fluorescent label exhibiting a hybridization-dependent fluorescent emission, wherein hybridization of the oligonucleotide probe to the target nucleic acid sequence alters interaction of the fluorescent label with the G residue, thereby increasing the fluorescent emission from the label,

illuminating the biological sample, and

monitoring the hybridization-dependent fluorescent emission.

7. The method of claim 6 wherein the G residue comprises a terminal residue of the oligonucleotide sequence.

8. The method of claim 7 wherein the locus of the target nucleic acid sequence has a C residue in the complementary location to the G residue.

9. The method of claim 8 wherein hybridization of the oligonucleotide sequence to the target nucleic acid creates an overhang adjacent to the C residue of the target nucleic acid.

10. The method of claim 9 wherein residues other than G are located at positions −

1, +1, and +2.

11. The method of claim 7 wherein guanine residues are absent from positions −

1 and +1 on the target nucleic acid sequence.

12. The method of claim 6 wherein the hybridization-dependent fluorescent emission is measured as a function of sample temperature.

13. The method of claim 6 wherein the probe and sample are combined in a solution having pH of >

8.0.

14. The method of claim 13 wherein the solution has a Tris concentration of about 200 mM.

15. The method of claim 13 wherein the fluorescent label is selected from the group consisting of fluorescein, fluorescein derivatives, and fluorescein-cyanine conjugates, and the concentration of cations is about 50-200 mM.

16. The method of claim 13 wherein the solution further comprises a buffer selected from the group consisting of Tris+, Tricine+, 2-amino-2-methyl-1-propanol, and of 2-amino-2-methyl -1,3-propanediol.

17. The method of claim 6 wherein the hybridization-dependent fluorescent emission is monitored during asymmetric PCR.

18. The method of claim 17 wherein about 45 PCR cycles are performed, and a pair of PCR primers are provided in a 1:

4 ratio.

19. The method of claim 17 wherein about 60 PCR cycles are performed, and a pair of PCR primers are provided in a 1:

8 ratio.

20. A method of analyzing a sample comprising a target nucleic acid sequence, comprising the steps of

combining the sample and an oligonucleotide probe to create a target-probe mixture, wherein the probe includes a virtual nucleotide having a fluorescent label positioned so that the magnitude of fluorescent emission from the fluorescent label is altered by hybridization of the probe to the target nucleic acid sequence,

illuminating the mixture, and

monitoring the fluorescent emission from the fluorescent label.

21. The method of claim 20 further comprising the steps of:

combining the mixture with a pair of oligonucleotide primers, wherein the oligonucleotide primers are configured for amplifying a selected segment of the target nucleic acid sequence,

adding a polymerase, and

amplifying the selected segment of the target nucleic acid sequence.

22. The method of claim 21 wherein the pair of primers have an annealing temperature, and the probe has a Tm 0 to 10°

C. below the annealing temperature.

23. The method of claim 21 wherein the fluorescent label is selected from the group consisting of fluorescein, fluorescein derivatives, and fluorescein-cyanine conjugates, the target nucleic acid sequence comprises a guanine residue in the complementary position to the virtual nucleotide, and the fluorescent emission is quenched upon hybridization of the oligonucleotide probe to the target nucleic acid sequence.

24. The method of claim 20 further comprising the step of amplifying a selected segment of the target nucleic acid sequence by a procedure selected from the group consisting of SDA, NASBA, CRCA, Q beta replicase mediated amplification, ICAN, and TMA.

25. The method of claim 20 wherein the fluorescent label is selected from the group consisting of fluorescein, fluorescein derivatives, cyanine derivatives, and fluorescein-cyanine conjugates, and hybridization of the probe to the target nucleic acid places the fluorescent label in a complementary position to a residue other than guanine and results in increased fluorescent emission.

26. The method of claim 25 wherein the residue other than guanine is adenine.

27. The method of claim 20 wherein the fluorescent emission is monitored as a function of temperature.

28. A method for determining the presence of a target nucleic acid sequence in a biological sample comprising:

combining the biological sample with a pair of primers configured for amplifying a selected segment of the target nucleic acid sequence and a fluorescent detecting entity consisting essentially of a single-labeled oligonucleotide probe,

wherein the single-labeled probe comprises an oligonucleotide having a sequence complementary to a locus of the selected segment of the target nucleic acid sequence, and having a fluorescent label exhibiting a sequence-specific hybridization-dependent emission attached thereto, wherein hybridization of the probe to the locus results in an increase in fluorescent emission of the fluorescent label,

adding a polymerase and amplifying the selected segment of the nucleic acid sequence through a plurality of amplification cycles,

illuminating the biological sample, and

monitoring the hybridization-dependent fluorescent emission.

29. The method of claim 28 further comprising the step of determining a maximum -df/dT as the probe dissociates from the target nucleic acid sequence.

30. The method of claim 28 wherein the fluorescent label is linked to a base of the oligonucleotide probe and the base is selected from the group consisting of, 4-nitroindole, 5-nitroindole, 6-nitroindole, and 3-nitropyrrole deoxynucleosides.

31. The method of claim 28 wherein the fluorescent label is linked to a base of the oligonucleotide probe and the base is selected from the group consisting of, inosine, 5-iodo-cytidine, and nubluarine deoxynucleosides, wherein a residue other than guanine is located on the target nucleic acid sequence at position +1 relative to the position of the label.

32. The method of claim 28 wherein the fluorescent label is attached to a guanine residue and the monitoring step includes monitoring the increased emission from the fluorescent label upon hybridization of the probe to the target nucleic acid.

33. The method of claim 28 wherein the fluorescent label is selected from the group consisting of cyanine dyes and LCRed 705.

34. The method of claim 28 wherein the fluorescent detecting entity is immobilized on a surface and the combining step includes placing the sample in contact with the surface.

35. The method of claim 28 further comprising

providing a second fluorescent detecting entity consisting essentially of a second single-labeled oligonucleotide probe, wherein the second single-labeled oligonucleotide probe comprises a second oligonucleotide sequence generally complementary to a second selected segment of the target nucleic acid sequence and having a second fluorescent label linked to an end of the second oligonucleotide sequence, the second fluorescent label exhibiting a hybridization-dependent fluorescent emission at a wavelength different from the fluorescent emission of the first probe, wherein hybridization of the second oligonucleotide probe to the second selected segment results in altered fluorescent emission from the second label and the altered fluorescent signal is independent of fluorescent emission of the first fluorescent detecting entity, and

monitoring the hybridization-dependent fluorescent emission of the second probe.

36. The method of claim 28 wherein the fluorescent label is attached to the 5′

terminal nucleotide of the oligonucleotide, and further comprising the steps of

combining the biological sample and the probe with a second oligonucleotide and a polymerase, and

amplifying the target nucleic acid sequence,

wherein the probe and the second oligonucleotide function as a pair of primers for amplification.

37. The method of claim 36 wherein the 5′

terminal nucleotide is an A or T residue.

38. A kit for analyzing a biological sample comprising a nucleic acid sequence, comprising:

a. a fluorescent detecting entity consisting essentially of a single-labeled oligonucleotide probe having an oligonucleotide comprising a base analog, the base analog linked to a fluorescent label, wherein said probe is configured to hybridize to a single-stranded locus of the segment so that the magnitude of fluorescent emission from the fluorescent label is increased by hybridization of the probe to the locus; and

b. components for amplification of the nucleic acid sequence.

39. The kit of claim 38 wherein the components include a pair of oligonucleotide primers configured for amplifying a segment of said nucleic acid sequence and a thermostable DNA polymerase.

40. The kit of claim 39 further comprising

a second pair of primers configured for amplifying a second segment of said nucleic acid sequence comprising a second single-stranded locus;

and

a second fluorescent detecting entity consisting essentially of a second single-labeled oligonucleotide probe having a second oligonucleotide linked to a second fluorescent label, wherein said second probe is configured to hybridize to the second locus so that the magnitude of the fluorescent emission from the second fluorescent label is increased or decreased by hybridization of the second probe to the target nucleic acid sequence.